Other News

New Pilot Study Indicates Niagen® May Reduce Inflammatory Cytokines in Stage D Heart Failure Patients

Niagen® (patented nicotinamide riboside) may reduce production of inflammatory cytokines in pilot study of Stage D heart failure patients LOS ANGELES–(BUSINESS WIRE)–ChromaDex Corp. (NASDAQ:CDXC) today announced the 11th published human trial on its patented NAD-boosting nutrient Niagen®, further highlighting its potential to support cardiovascular health in humans. A NIH funded study […]

Foldax Named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020

Tria Heart Valve Made with Proprietary LifePolymer Reimagines Material, Design and Manufacturing to Solve Long-Standing Heart Valve Issues SALT LAKE CITY–(BUSINESS WIRE)–Foldax® announced today that it has been selected as a finalist in the Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma, […]

Endospan Receives FDA IDE Approval to Initiate a Pivotal Study of the NEXUS™ Aortic Arch Stent Graft System

HERZLIA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf endovascular repair of aortic arch disease received approval from FDA of an investigational device exemption, or IDE, to start the TRIOMPHE study on the NEXUS™ Aortic Arch Stent Graft System (hereinafter referred to as NEXUSTM). Earlier this year, FDA granted NEXUSTM designation as a […]

American Society for Preventive Cardiology (ASPC) Announces Newly Elected President Peter P. Toth, MD, PhD, FASPC

JACKSONVILLE, Fla., Aug. 17, 2020 /PRNewswire/ — During the ASPC annual business meeting during the recent 2020 ASPC Virtual Summit on CVD Prevention, Peter P. Toth, MD, PhD, FASPC was officially elected as the President of the American Society for Preventive Cardiology (ASPC).  ASPC is a national multidisciplinary membership organization dedicated to the prevention […]

Transit Scientific Announces First Worldwide Cases Performed with XO Cross Microcatheter Platform

First clinical cases completed using the new non-tapered, metal-alloy, peripheral catheter platform. PARK CITY, Utah, Aug. 17, 2020 /PRNewswire/ — Transit Scientific announced completion of the first clinical cases in the world using the XO Cross® Microcatheter platform. Dr. James McGuckin of the Lehigh Valley Vascular Institute (LVVI) performed the procedures using the XO Cross […]

Semler Scientific Expands Board of Directors with Appointment of Industry Veteran Daniel Messina

SAN JOSE, Calif., Aug. 17, 2020 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Daniel Messina, an experienced and well regarded health services executive and entrepreneur, to its Board of Directors, effective August 13, 2020. […]

Neovasc Announces Partial Prepayment of Convertible Debenture

VANCOUVER and MINNEAPOLIS, Aug. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase Agreement dated […]

Philips introduces OmniWire, the world’s first solid core pressure guide wire for coronary artery interventional procedures

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of OmniWire, the world’s first solid core pressure wire for coronary artery interventional procedures. With its breakthrough solid core construction, physicians can more easily maneuver the wire in the patient’s circulatory system to […]

AngioDynamics Announces First Patient Enrolled in PATHFINDER I Registry Examining Long-Term Effectiveness and Safety of Auryon Atherectomy System

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the enrollment of the first patient in the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD-05). The PATHFINDER I Registry is a pilot study to evaluate […]